Indian Stock Market News, Equity Market and Sensex Today in India | Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

A strong start to the week
Tue, 27 Jan Closing

The Indian markets surged higher as buying activity increased during the final hour of trade. The BSE-Sensex ended with gains of about 290 points or 1%, while NSE-Nifty closed higher by about 75 points or 0.9%. Barring stocks from the information technology and metals spaces, gains were seen across the board with banking and capital goods stocks leading the pack. Midcaps and smallcaps closed the day on a firm note as well, with their respective indices up by about 0.8% each.

Asian stocks ended firm, while stocks in Europe were trading weak. The rupee was trading at Rs 61.46 to the dollar at the time of writing.

Auto Stocks were in demand today with Tata Motors and Ashok Leyland leading the pack of gainers. Passenger car manufacturer Maruti Suzuki ended the day on a firm note today on the back of company reporting a good set of results for the quarter ended December 2014. The company reported a profit growth of 18% YoY while revenues were up by about 15% YoY. As per the company, it was the higher volumes coupled with cost reduction efforts as well as favourable forex movement which led to a faster rise in profits. Sales volumes for the quarter were higher by 12% YoY at about 323,911 units as compared to 288,151 units in the same period last fiscal. From this, domestic sales formed about 91% of volumes (295,202 units) as against 92% or 268,185 units in the same period last fiscal, while exports formed the balance. Maruti closed higher by about 2.2% today.

Stocks of pharmaceutical companies ended the day on a firm note with Cipla and GSK Pharma leading the pack of gainers. As per as leading business daily, drug major Ranbaxy has stated that the US Food and Drug Administration (FDA) has forfeited the 180 day exclusivity of its tablets which are used to treat stomach and esophagus problems. The company has stated that it would be pursuing all legal routes to preserve its rights. It is believed that the US market size of this drug (Nexium) is approximately US$ 2 bn and since Ranbaxy was holding 6-month exclusivity for this drug, this was an important opportunity for Ranbaxy.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Read the latest Market Commentary


What else is happening in the markets today? Dig in...

Equitymaster requests your view! Post a comment on "A strong start to the week". Click here!

  

Related Views on News

MARUTI SUZUKI Announces Quarterly Results (3QFY21); Net Profit Up 24.1% (Quarterly Result Update)

Jan 28, 2021 | Updated on Jan 28, 2021

For the quarter ended December 2020, MARUTI SUZUKI has posted a net profit of Rs 19 bn (up 24.1% YoY). Sales on the other hand came in at Rs 222 bn (up 7.4% YoY). Read on for a complete analysis of MARUTI SUZUKI's quarterly results.

MARUTI SUZUKI 2019-20 Annual Report Analysis (Annual Result Update)

Dec 7, 2020 | Updated on Dec 7, 2020

Here's an analysis of the annual report of MARUTI SUZUKI for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of MARUTI SUZUKI. Also includes updates on the valuation of MARUTI SUZUKI.

MARUTI SUZUKI Announces Quarterly Results (1QFY21); Net Profit Down 117.4% (Quarterly Result Update)

Jul 30, 2020 | Updated on Jul 30, 2020

For the quarter ended June 2020, MARUTI SUZUKI has posted a net profit of Rs 2 bn (down 117.4% YoY). Sales on the other hand came in at Rs 41 bn (down 79.2% YoY). Read on for a complete analysis of MARUTI SUZUKI's quarterly results.

MARUTI SUZUKI 2018-19 Annual Report Analysis (Annual Result Update)

Aug 6, 2019 | Updated on Aug 6, 2019

Here's an analysis of the annual report of MARUTI SUZUKI for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of MARUTI SUZUKI. Also includes updates on the valuation of MARUTI SUZUKI.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps (Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market (Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

I Believe the Investment of the Year Will Be...

Feb 19, 2021

In this episode, ace trader Brijesh Bhatia talks to us about the best investments of 2021, his profitable trading system, and much more.

The Hidden Tesla in My Great Indian Wealth Project (Profit Hunter)

Feb 23, 2021

An Indian company founded three decades ago in a garage caught my attention...

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

S&P BSE AUTO


Mar 2, 2021 (Close)

S&P BSE AUTO 5-YR ANALYSIS

COMPARE COMPANY

MARKET STATS